ES2046331T3 - Metodo para preparar una composicion de aminoacidos para el apoyo nutrimental paramental. - Google Patents

Metodo para preparar una composicion de aminoacidos para el apoyo nutrimental paramental.

Info

Publication number
ES2046331T3
ES2046331T3 ES198888850373T ES88850373T ES2046331T3 ES 2046331 T3 ES2046331 T3 ES 2046331T3 ES 198888850373 T ES198888850373 T ES 198888850373T ES 88850373 T ES88850373 T ES 88850373T ES 2046331 T3 ES2046331 T3 ES 2046331T3
Authority
ES
Spain
Prior art keywords
composition
ketoglutarate
asparagine
glutamine
alpha
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888850373T
Other languages
English (en)
Inventor
Erik Vinnars
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vinnars Erik AB
Original Assignee
Vinnars Erik AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vinnars Erik AB filed Critical Vinnars Erik AB
Application granted granted Critical
Publication of ES2046331T3 publication Critical patent/ES2046331T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION SE REFIEE A UNA COMPOSICION PARA UN TRATAMIENTO DE SOPORTE NUTRICIONAL PARENTERAL TERAPEUTICA, ESPECIALMENTE POSTOPERATIROI Y POSTTRAUMATICO. LA INVENCION SE REFIERE TAMBIEN A LA UTILIZACION DE L - GLUTAMINA Y/O SU DERIVADO ALFA CETOGLUTARATO Y OPCIONALMENTE L - ASPARAGINA Y/O SU DERIVADO ACETOACETATO PARA LA PREPARACION DE UNA COMPOSICION PARA TRATAMIENTO DE SOPORTE NUTRICIONAL PARENTERAL TERAPEUTICO, ESPECIALMENTE POSTOPERATORIO Y POSTTRAUMATICO QUE SE CARACTERIZA POR L - GLUTAMINA Y/O ALFA - CETOGLUTARATO, Y OPCIONALMENTE L ASPARAGINA Y/O ACETOACETATO, DISUELTOS EN AGUA Y FILTRADOS Y ESTERILIZADOS SE A/ADEN EN FORMA DE ALMACEN FRIO Y SECADO CONGELADO U OTRA FORMA DE POLVOS ESTERILES A UNA SOLUCION NUTRIENTE AMINOACIDA COMERCIAL INMEDIATAMENTE ANTES DEL TRATAMIENTO TERAPEUTICO.
ES198888850373T 1987-10-29 1988-10-28 Metodo para preparar una composicion de aminoacidos para el apoyo nutrimental paramental. Expired - Lifetime ES2046331T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE8704217A SE8704217D0 (sv) 1987-10-29 1987-10-29 Aminosyrakomposition for parenteral neringstillforsel

Publications (1)

Publication Number Publication Date
ES2046331T3 true ES2046331T3 (es) 1994-02-01

Family

ID=20370052

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888850373T Expired - Lifetime ES2046331T3 (es) 1987-10-29 1988-10-28 Metodo para preparar una composicion de aminoacidos para el apoyo nutrimental paramental.

Country Status (10)

Country Link
EP (2) EP0398879A1 (es)
JP (1) JP2728134B2 (es)
AT (1) ATE81468T1 (es)
AU (1) AU2623888A (es)
CA (1) CA1314232C (es)
DE (1) DE3875322T2 (es)
ES (1) ES2046331T3 (es)
GR (1) GR3006085T3 (es)
SE (1) SE8704217D0 (es)
WO (1) WO1989003688A1 (es)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8902544L (sv) * 1989-07-17 1991-01-18 Kabivitrum Ab Beredning foer naeringstillfoersel, samt saett foer dess framsaellning
AU8513191A (en) * 1990-09-10 1992-03-30 Austin L. Shug Composition and method for protecting the heart during reperfusion
SE9003844L (sv) * 1990-12-03 1992-06-04 Kabi Pharmacia Ab Naeringstillsats
US5334380A (en) * 1991-09-27 1994-08-02 Board Of Regents, The University Of Texas System Anti-endotoxin, interleukin-1 receptor antagonist and anti-tumor necrosis factor antibody with arginine-free formulations for the treatment of hypotension
US5286739A (en) * 1991-09-27 1994-02-15 Board Of Regents, University Of Texas System Parenteral formulations for the inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor
US5374651A (en) * 1991-09-27 1994-12-20 Board Of Regents, The University Of Texas System Methods and compositions for the treatment of hypotension with arginine free essential and essential amino acids and arginine derivatives
CA2116684A1 (en) * 1991-09-27 1993-04-01 Robert G. Kilbourn Amino acids containing parenteral formulations for the treatment of hypotension and related pathologies
GB9121467D0 (en) * 1991-10-10 1991-11-27 Sandoz Nutrition Ltd Improvements in or relating to organic compounds
SE9201584D0 (sv) * 1992-05-20 1992-05-20 Vinnars Erik Ab Use of alpha-ketoglutarate
US5646187A (en) * 1992-05-20 1997-07-08 Ab Erik Vinnars Use of alpha-ketoglutarate
US5276018A (en) * 1992-07-17 1994-01-04 Brigham And Women's Hospital Composition comprising amino acids and methods for decreasing muscle breakdown
FR2711529B1 (fr) * 1993-10-28 1996-07-05 Clintec Nutrition Cy Composition à base d'acides aminés destinée au traitement d'une infection ou d'une agression engendrant une réaction inflammatoire, chez les animaux et chez l'homme.
SE9303691D0 (sv) * 1993-11-09 1993-11-09 Gramineer Ab New beverage
SE9402027D0 (sv) * 1994-06-10 1994-06-10 Pharmacia Ab Energy substrates
WO1999025331A1 (en) * 1997-11-13 1999-05-27 University Of Florida Use of ketoacids together with amino acids for enhancing muscle performance and recovery from fatigue
US6905707B2 (en) 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
WO2000068251A1 (en) 1999-05-07 2000-11-16 The University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes
US20020147237A1 (en) * 2001-01-31 2002-10-10 Lars Wiklund Preservation of bodily protein
EP1618878A1 (en) * 2003-04-30 2006-01-25 Ajinomoto Co., Inc. Body-temperature lowering depressant
JP4528925B2 (ja) * 2003-05-30 2010-08-25 独立行政法人理化学研究所 アミノ酸組成物及び補液
JPWO2005027898A1 (ja) * 2003-09-19 2007-11-15 独立行政法人理化学研究所 アミノ酸組成物
JP4124260B2 (ja) 2004-09-17 2008-07-23 味の素株式会社 機能性消化管障害予防・改善剤及び食品
JP5177785B2 (ja) * 2004-11-02 2013-04-10 味の素株式会社 周術期患者用薬剤
PL379512A1 (pl) * 2006-04-21 2007-10-29 Sgp & Sons Ab Nowe metody i ich zastosowanie

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5916817A (ja) * 1982-07-16 1984-01-28 Eisai Co Ltd アミノ酸輸液
JPS5927817A (ja) * 1982-08-05 1984-02-14 Tanabe Seiyaku Co Ltd アミノ酸輸液
JPS6178719A (ja) * 1984-09-25 1986-04-22 Tanabe Seiyaku Co Ltd 総合輸液剤
EP0250559A1 (en) 1985-12-18 1988-01-07 VEECH, Richard L. Parenteral nutrition therapy with amino acids
JPS62221621A (ja) * 1986-03-24 1987-09-29 Tanabe Seiyaku Co Ltd 総合輸液剤

Also Published As

Publication number Publication date
AU2623888A (en) 1989-05-23
JPH03500775A (ja) 1991-02-21
GR3006085T3 (es) 1993-06-21
SE8704217D0 (sv) 1987-10-29
JP2728134B2 (ja) 1998-03-18
EP0318446B1 (en) 1992-10-14
EP0398879A1 (en) 1990-11-28
DE3875322D1 (de) 1992-11-19
WO1989003688A1 (en) 1989-05-05
CA1314232C (en) 1993-03-09
ATE81468T1 (de) 1992-10-15
DE3875322T2 (de) 1993-05-13
EP0318446A1 (en) 1989-05-31

Similar Documents

Publication Publication Date Title
ES2046331T3 (es) Metodo para preparar una composicion de aminoacidos para el apoyo nutrimental paramental.
GB1507951A (en) Amino acid formulations
AU703484B2 (en) Peptides for tissue and cell culture media
DE69723812D1 (de) Aminosäurezusammensetzungen
SE9402156D0 (sv) Farmaceutiska kompositioner innehållande salterna av s(+)-2- (4-isobutylfenyl)-propionsyra med basiska aminosyror
EP0182356B1 (en) Nutrient compositions
FR2435247A1 (fr) Solution d'amino-acides pour la nutrition par voie intraveineuse
DE3784743D1 (en) Hydroxamsaeuren.
EP0353108B1 (fr) Procédé de stabilisation des vaccins et associations de vaccins à virus atténués conservés sous forme lyophilisée, et compositions obtenues
CA2386826A1 (en) Use of l-carnitine and its alkanoyl derivatives as osmotic agents in solutions for peritoneal dialysis
DE59001192D1 (de) Waessrige zusammensetzung fuer die parenterale ernaehrung.
GB985498A (en) Improvements in or relating to plasmin preparations
US4085207A (en) Amino acid parenteral solution containing reducing sugar
PT1296675E (pt) Composicoes a base de aminoacidos apropriadas para o tratamento da insuficienciacardiaca
GB1442154A (en) Composition for promotion of protein synthesis and suppression of urea formation in the body
Katz et al. Role of valine and isoleucine as regulators of actinomycin peptide formation by Streptomyces chrysomallus
JPWO2021158831A5 (es)
RU94024392A (ru) Минерально-аминокислотный концентрат
RU2018113706A (ru) Стабильные высококонцентрированные водные композиции ранибизумаба с пролонгированным действием при интравитреальном введении для медицинского применения
GB1496254A (en) Nutritive infusion solution and its production
US3639383A (en) Complexes of a.c.t.h. peptides and polyphosphoric acids
GB1444621A (en) Composition for promotion of protein synthesis and suppression of urea formation in the body utilizing alpha-hydroxy-acid analogues of amino acids
Kim Effect of larva gut enzyme on pollen
SU527182A1 (ru) Способ получени белковых гидролизатов из водорослей
CS433286A3 (en) Peptides with 1-amino-1-cycloalkane carboxylic acid

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 318446

Country of ref document: ES